{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:12:25Z","timestamp":1760141545470,"version":"build-2065373602"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ejso.2021.10.011","type":"journal-article","created":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T18:47:07Z","timestamp":1635274027000},"page":"268-274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Uterine serous carcinoma: role of surgery, risk factors and oncologic outcomes. Experience of a tertiary center"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5684-8225","authenticated-orcid":false,"given":"Antonino","family":"Ditto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3744-2668","authenticated-orcid":false,"given":"Umberto","family":"Leone Roberti Maggiore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4863-1747","authenticated-orcid":false,"given":"Fabio","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Bogani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4444-9526","authenticated-orcid":false,"given":"Salvatore","family":"Lo Vullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Brusadelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biagio","family":"Paolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Ducceschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara","family":"Mantiero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Chiappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Signorelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariateresa","family":"Evangelista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6208-4084","authenticated-orcid":false,"given":"Luigi","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Raspagliesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejso.2021.10.011_bib1","first-page":"7","article-title":"Cancer statistics, 2020","volume":"71","author":"Siegel","year":"2021","journal-title":"Ca - Cancer J Clin"},{"issue":"11","key":"10.1016\/j.ejso.2021.10.011_bib2","first-page":"615","article-title":"Tubal (serous) carcinoma of the endometrium","volume":"105","author":"Lauchlan","year":"1981","journal-title":"Arch Pathol Lab Med"},{"year":"2014","series-title":"WHO classification of tumours of female reproductive organs","author":"Kurman","key":"10.1016\/j.ejso.2021.10.011_bib3"},{"issue":"10","key":"10.1016\/j.ejso.2021.10.011_bib4","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/cncr.20645","article-title":"Uterine serous and grade 3 endometrioid carcinomas: is there a survival difference?","volume":"101","author":"Boruta","year":"2004","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2021.10.011_bib5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ygyno.2013.01.004","article-title":"Early stage uterine serous carcinoma: management updates and genomic advances","volume":"129","author":"Fader","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2021.10.011_bib6","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1002\/cncr.24247","article-title":"Platinum\/taxane-based chemotherapy with or with- out radiation therapy favorably impacts survival out- comes in stage I uterine papillary serous carcinoma","volume":"115","author":"Fader","year":"2009","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2021.10.011_bib7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2005.06.012","article-title":"Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with ad- juvant platinum-based chemotherapy","volume":"98","author":"Kelly","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2021.10.011_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2021.10.011_bib9","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ygyno.2016.10.016","article-title":"Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: an NRG Oncology\/Gynecologic Oncology Group ancillary analysis","volume":"143","author":"Fader","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2021.10.011_bib10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ajog.2004.03.008","article-title":"Hysteroscopic injection of tracers in sentinel node detection of endometrial cancer: a feasibility study","volume":"191","author":"Raspagliesi","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejso.2021.10.011_bib11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jmig.2014.08.009","article-title":"Sentinel node mapping using hysteroscopic injection of indocyanine green and laparoscopic near-infrared fluorescence imaging in endometrial cancer staging","volume":"22","author":"Ditto","year":"2015","journal-title":"J\u00a0Minim Invasive Gynecol"},{"issue":"3","key":"10.1016\/j.ejso.2021.10.011_bib12","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.ygyno.2019.03.254","article-title":"Sentinel node mapping vs. lymphadenectomy in endometrial cancer: a systematic review and meta-analysis","volume":"153","author":"Bogani","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2021.10.011_bib13","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1214\/08-AOAS169","article-title":"Random survival forests","volume":"2","author":"Ishwaran","year":"2008","journal-title":"Ann Appl Stat"},{"key":"10.1016\/j.ejso.2021.10.011_bib14","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.2147\/CMAR.S179566","article-title":"Clinicopathological and survival analysis of uterine papillary serous carcinoma: a single institutional review of 106 cases","volume":"10","author":"Wang","year":"2018","journal-title":"Cancer Manag Res"},{"issue":"6","key":"10.1016\/j.ejso.2021.10.011_bib15","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1097\/IGC.0000000000001272","article-title":"Prognostic factors of uterine serous carcinoma-A multicenter study","volume":"28","author":"Zhong","year":"2018","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2021.10.011_bib16","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3390\/cancers12030686","article-title":"Pathogenesis and clinical management of uterine serous carcinoma","volume":"12","author":"Zhang","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ejso.2021.10.011_bib17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ygyno.2019.10.005","article-title":"Sentinel lymph node mapping alone compared to more extensive lymphadenectomy in patients with uterine serous carcinoma","volume":"156","author":"Basaran","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"15","key":"10.1016\/j.ejso.2021.10.011_bib18","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1158\/1078-0432.CCR-20-0953","article-title":"Randomized phase II trial of carboplatin\u2013 paclitaxel compared with carboplatin\u2013paclitaxel\u2013trastuzumab in advanced (Stage III\u2013IV) or recurrent uterine serous carcinomas that overexpress Her2\/Neu (NCT01367002): updated overall survival analysis","volume":"26","author":"Fader","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.ejso.2021.10.011_bib19","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/IGC.0b013e3181b7a1d5","article-title":"Pure papillary serous tumors of the endometrium: a clinicopathological analysis of 61 cases from a single institution","volume":"19","author":"Benito","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejso.2021.10.011_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijsu.2016.06.041","article-title":"Optimal cytoreduction, depth of myometrial invasion, and age are independent prognostic factors for survival in women with uterine papillary serous and clear cell carcinomas","volume":"32","author":"Solmaz","year":"2016","journal-title":"Int J Surg"},{"issue":"2","key":"10.1016\/j.ejso.2021.10.011_bib21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ygyno.2014.02.010","article-title":"Impact of management on the prognosis of pure uterine papillary serous cancer \u2013 a Taiwanese Gynecologic Oncology Group (TGOG) study","volume":"133","author":"Huang","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2021.10.011_bib22","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ygyno.2003.08.018","article-title":"Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases","volume":"91","author":"Slomovitz","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2021.10.011_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/PGP.0000000000000113","article-title":"Significance of lymphovascular space invasion in uterine serous carcinoma: what matters more; extent or presence?","volume":"34","author":"Winer","year":"2015","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"10.1016\/j.ejso.2021.10.011_bib24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/IGC.0000000000000569","article-title":"Uterine papillary serous carcinoma: a single-institution review of 62 cases","volume":"26","author":"Black","year":"2016","journal-title":"Int J Gynecol Cancer"},{"issue":"10","key":"10.1016\/j.ejso.2021.10.011_bib25","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1002\/cncr.24247","article-title":"Uterine Papillary Serous Carcinoma (UPSC) Consortium. Platinum\/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma","volume":"115","author":"Fader","year":"2009","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2021.10.011_bib26","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ygyno.2007.05.039","article-title":"Role of cytoreduction in stage III and IV uterine papillary serous carcinoma","volume":"107","author":"Thomas","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2021.10.011_bib27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/IGC.0b013e31823c6e36","article-title":"Prognostic determinants in patients with stage I uterine papillary serous carcinoma: a 15-year multi-institutional review","volume":"22","author":"Growdon","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejso.2021.10.011_bib28","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.2147\/CMAR.S179566","article-title":"Clinicopathological and survival analysis of uterine papillary serous carcinoma: a single institutional review of 106 cases","volume":"10","author":"Wang","year":"2018","journal-title":"Cancer Manag Res"},{"issue":"2","key":"10.1016\/j.ejso.2021.10.011_bib29","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/gyno.2001.6159","article-title":"Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (Stage I-III) disease","volume":"81","author":"Bristow","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2021.10.011_bib30","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ygyno.2015.01.544","article-title":"Impact of adjuvant chemotherapy and pelvic radiation on pattern of recurrence and outcome in stage I non-invasive uterine papillary serous carcinoma. A multi-institution study","volume":"137","author":"Mahdi","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2021.10.011_bib31","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1634\/theoncologist.2016-0062","article-title":"Chemotherapy for endometrial cancer in adjuvant and advanced DiseaseSettings","volume":"21","author":"Bestvina","year":"2016","journal-title":"Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2021.10.011_bib32","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ygyno.2011.09.005","article-title":"The importance of chemotherapy andradiation in uterine papillary serous carcinoma","volume":"123","author":"Viswanathan","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2021.10.011_bib33","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/COC.0000000000000541","article-title":"Uterine papillary serous carcinoma arising in a polyp: a multicenter retrospective analysison 75 patients","volume":"42","author":"Di Mandato","year":"2019","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2021.10.011_bib34","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ygyno.2007.05.044","article-title":"Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma","volume":"107","author":"Thomas","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.ejso.2021.10.011_bib35","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/ijgc-00009577-200602001-00043","article-title":"Treatment of uterine papillary serous carcinoma with platinum-based chemotherapy and paclitaxel","volume":"16","author":"Vaidya","year":"2006","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2021.10.011_bib36","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1006\/gyno.2000.5746","article-title":"Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994","volume":"77","author":"Craighead","year":"2000","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2021.10.011_bib37","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ygyno.2009.06.011","article-title":"Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review","volume":"115","author":"Boruta","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2021.10.011_bib38","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ygyno.2009.07.030","article-title":"An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC)","volume":"115","author":"Fader","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2021.10.011_bib39","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1097\/IGC.0b013e318267f7a0","article-title":"Analysis of treatment failures and survival of patients with uterine papillary serous carcinoma: a Cooperation Task Force (CTF) Study","volume":"22","author":"Gadducci","year":"2012","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2021.10.011_bib40","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ygyno.2009.07.004","article-title":"Treatment of early-stage uterine papillary serous carcinoma at Roswell Park Cancer Institute, 1992-2006","volume":"115","author":"Tchabo","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2021.10.011_bib41","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ygyno.2008.11.016","article-title":"Stage II uterine papillaryserous carcinoma: carboplatin\/paclitaxel chemotherapy improves recurrence and survival outcomes","volume":"112","author":"Fader","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2021.10.011_bib42","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/107327480901600107","article-title":"Non-endometrioid adenocarci-noma of the uterine corpus: a review of selected histological subtypes","volume":"16","author":"Mendivil","year":"2009","journal-title":"Cancer Control"},{"issue":"2","key":"10.1016\/j.ejso.2021.10.011_bib43","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ygyno.2007.10.037","article-title":"Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN)","volume":"108","author":"Goldberg","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2021.10.011_bib44","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ygyno.2005.08.037","article-title":"Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: a phase II study of the Gynecologic Oncology Group","volume":"100","author":"Sutton","year":"2006","journal-title":"Gynecol Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798321007599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798321007599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:43:21Z","timestamp":1760060601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798321007599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0748798321007599"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2021.10.011","relation":{},"ISSN":["0748-7983"],"issn-type":[{"type":"print","value":"0748-7983"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uterine serous carcinoma: role of surgery, risk factors and oncologic outcomes. Experience of a tertiary center","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2021.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}